✦ LIBER ✦

Pharmacokinetics of Meropenem 0.5 and 2 g Every 8 Hours as a 3-Hour Infusion

✍ Scribed by Dr. Prachi K. Dandekar; Dr. Dana Maglio; Ms. Christina A. Sutherland; Dr. Charles H. Nightingale; Dr. David P. Nicolau

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacokinetics and pharmacodynamic eff

✍ Jean L. Grem; Mary Quinn; Abdel Ismail; Chris H. Takimoto; Richard Lush; David J 📂 Article 📅 2001 🏛 Springer 🌐 English ⚖ 243 KB

Phase I and pharmacokinetic study of ect

✍ Twelves, C.J.; Vermorken, J.; Bowman, A.; Simpson, A.; Smyth, J.; Höppener, F.; 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 252 KB

A phase I and pharmacokinetic study of R

✍ Abigerges, D; Catimel, G; Klink Alakl, M; Bruno, R; Chabot, G; Ardiet, C; Nieman 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 143 KB

Phase I/II tolerability/pharmacokinetic

✍ Sophie D. Fosså; Asbjørn Flokkmann; Mona Heier; Magne Aas; Brit Moe; R. Heintz; 📂 Article 📅 1986 🏛 Springer 🌐 English ⚖ 483 KB

A phase I and pharmacokinetic study of D

📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 144 KB

550 Phase I and pharmacokinetic (PK) stu

✍ S.Q. Chu; G. Schwartz; M. Beeram; A. Patniak; M. Mita; J. Jimeno; L. Lopez-Laraz 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 273 KB